|
|
|
|
LEADER |
00000nam a22000005i 4500 |
001 |
978-3-642-28965-1 |
003 |
DE-He213 |
005 |
20220119045459.0 |
007 |
cr nn 008mamaa |
008 |
120626s2012 gw | s |||| 0|eng d |
020 |
|
|
|a 9783642289651
|9 978-3-642-28965-1
|
024 |
7 |
|
|a 10.1007/978-3-642-28965-1
|2 doi
|
050 |
|
4 |
|a QD1-999
|
072 |
|
7 |
|a PN
|2 bicssc
|
072 |
|
7 |
|a SCI013000
|2 bisacsh
|
072 |
|
7 |
|a PN
|2 thema
|
082 |
0 |
4 |
|a 540
|2 23
|
245 |
1 |
0 |
|a Protein-Protein Interactions
|h [electronic resource] /
|c edited by Michael D. Wendt.
|
250 |
|
|
|a 1st ed. 2012.
|
264 |
|
1 |
|a Berlin, Heidelberg :
|b Springer Berlin Heidelberg :
|b Imprint: Springer,
|c 2012.
|
300 |
|
|
|a XVIII, 262 p.
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
347 |
|
|
|a text file
|b PDF
|2 rda
|
490 |
1 |
|
|a Topics in Medicinal Chemistry,
|x 1862-247X ;
|v 8
|
505 |
0 |
|
|a Protein-Protein Interactions as Drug Targets -- Targeting the MDM2-p53 Protein-Protein Interaction for New Cancer Therapeutics -- The Development of Small-Molecule IAP Antagonists for the Treatment of Cancer -- Protein-Protein Interaction Targets to Inhibit HIV-1 Infection -- Inhibitors of Protein-Protein Interactions in Paramyxovirus Fusion - a Focus on Respiratory Syncytial Virus -- Rational Design Strategies for Developing Synthetic Inhibitors of Helical Protein Interfaces -- The Discovery of Navitoclax, a Bcl-2 Family Inhibitor.
|
520 |
|
|
|a Michael D. Wendt Protein-Protein Interactions as Drug Targets Shaomeng Wang , Yujun Zhao , Denzil Bernard , Angelo Aguilar , Sanjeev Kumar Targeting the MDM2-p53 Protein-Protein Interaction for New Cancer Therapeutics Kurt Deshayes , Jeremy Murray , Domagoj Vucic The Development of Small-Molecule IAP Antagonists for the Treatment of Cancer John F. Kadow , David R. Langley , Nicholas A. Meanwell , Michael A. Walker , Kap-Sun Yeung , Richard Pracitto Protein-Protein Interaction Targets to Inhibit HIV-1 Infection Nicholas A. Meanwell , David R. Langley Inhibitors of Protein-Protein Interactions in Paramyxovirus Fusion - a Focus on Respiratory Syncytial Virus Andrew B. Mahon , Stephen E. Miller , Stephen T. Joy , Paramjit S. Arora Rational Design Strategies for Developing Synthetic Inhibitors of Helical Protein Interfaces Michael D. Wendt The Discovery of Navitoclax, a Bcl-2 Family Inhibitor.
|
650 |
|
0 |
|a Chemistry.
|
650 |
1 |
4 |
|a Chemistry.
|
700 |
1 |
|
|a Wendt, Michael D.
|e editor.
|4 edt
|4 http://id.loc.gov/vocabulary/relators/edt
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer Nature eBook
|
776 |
0 |
8 |
|i Printed edition:
|z 9783642289668
|
776 |
0 |
8 |
|i Printed edition:
|z 9783642439551
|
776 |
0 |
8 |
|i Printed edition:
|z 9783642289644
|
830 |
|
0 |
|a Topics in Medicinal Chemistry,
|x 1862-247X ;
|v 8
|
856 |
4 |
0 |
|u https://doi.uam.elogim.com/10.1007/978-3-642-28965-1
|z Texto Completo
|
912 |
|
|
|a ZDB-2-CMS
|
912 |
|
|
|a ZDB-2-SXC
|
950 |
|
|
|a Chemistry and Materials Science (SpringerNature-11644)
|
950 |
|
|
|a Chemistry and Material Science (R0) (SpringerNature-43709)
|